Fluticasone-salmeterol combination does not cause more serious asthma-related events than fluticasone in moderate-to-severe asthma, indicated a study. Routine use of short-acting beta blockers like ...

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram dose ...

asthma The risk of serious asthma-related events was no greater with the combination of long-acting beta-agonist (LABA) salmeterol + the inhaled glucocorticoid, fluticasone propionate, versus ...

October 27, 2006 (Salt Lake City) -- New findings from the landmark Towards a Revolution in COPD Health (TORCH) study show that high-dose inhaled fluticasone propionate 500 mg/salmeterol 50 mg ( ...

Fluticasone propionate/salmeterol MDPI demonstrated, in the double-blind studies, clinically relevant and greater benefit at all doses (50/12.5, 100/12.5, and 200/12.5 mcg BID nominal delivered doses) ...

The Towards a Revolution in COPD Health (TORCH) trial evaluated the effect of treatments for chronic obstructive pulmonary disease (COPD) on morbidity and mortality outcomes. The study randomized ...

This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease ...

Review the side-effects of Salmeterol and Fluticasone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...

Initiation of fluticasone propionate–salmeterol after a COPD-related hospitalization or ED visit decreased the risk of a recurrent event and reduced COPD-related medical costs. Objectives: To quantify ...

Cipla has launched its salmeterol/fluticasone metered-dose inhaler in Germany and Sweden, according to a press release. The product will be branded as Serroflo in Germany and Salmeterol/Fluticasone ...

- The first and only family of digital, breath-actuated inhalers with built-in sensors that track inhaler events and measure inspiratory flow - Digihaler® app provides patients the ability to view and ...

HealthDay News — For patients with a history of chronic obstructive pulmonary disease (COPD) exacerbations, indacaterol-glycopyrronium is more effective for prevention of exacerbations than salmeterol ...